{
  "docId": "019dd923-622c-750b-8b9a-40e2965928db",
  "docSlug": "e5bffbaac707",
  "documentTitle": "TransMedics (TMDX)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 219,
  "pageCount": 342,
  "prevPage": 218,
  "nextPage": 220,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "This is a classic activist short-seller slide focusing on management/key personnel red flags.",
  "elementsJson": [
    "paragraph",
    "screenshot"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/219",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-219",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Saverio LaFrancesca, a “Principal Cardiothoracic Surgeon,” was previously the President and Chief Medical Officer of Biostage (NASDAQ: BSTG), a micro-cap pump-and-dump engaged in quackery and which was involved with the notorious surgeon Paolo Macchiarini.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-5373-719d-a983-0ee29ca4c680",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.8,
        "x": 0.073,
        "y": 0.51
      },
      "kind": "image",
      "text": "Harvard Apparatus Regenerative Technology Promotes Chief Medical Officer Saverio La Francesca, M.D. to Executive Vice President\n-Dr. La Francesca leads scientific and clinical development including HART's second-generation bioengineered organ implant products-\nHarvard Apparatus Regenerative Technology Changes Name to Biostage, Inc. (NASDAQ: BSTG)",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec90df8a-6e4e-445b-a909-2ea8eea8a1d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“bioengineered trachea implant” – the initial surgical use of which “was led by Professor Paolo Macchiarini” — per the BSTG S-1.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-5373-719d-a983-12418ef30660",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.76,
        "x": 0.073,
        "y": 0.905
      },
      "kind": "source-note",
      "text": "Source: Biostage S-1 https://www.sec.gov/Archives/edgar/data/1563665/000155837022010152/tmb-20220621xs1.htm; https://www.businesswire.com/news/home/20150812005293/en/Harvard-Apparatus-Regenerative-Technology-Promotes-Chief-Medical-Officer-Saverio-La-Francesca-M.D.-to-Executive-Vice-President; https://www.prnewswire.com/news-releases/harvard-apparatus-regenerative-technology-changes-name-to-biostage-inc-nasdaq-bstg-300243888.html",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77468c21-5b46-43d2-b919-c94437b8a4d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.052,
        "w": 0.77,
        "x": 0.073,
        "y": 0.441
      },
      "kind": "subtitle",
      "text": "Press release announcing Saveria La Francesco promotion and Harvard Apparatus name change to Biostage, 2015 and 2016 respectively",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a29fae4-8a22-429c-9c15-baa13f525ed0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.348,
        "w": 0.865,
        "x": 0.073,
        "y": 0.071
      },
      "kind": "title",
      "text": "However, he is a sideshow relative to the far more suspect backgrounds of other TransMedics surgeons. Saverio LaFrancesca, a \"Principal Cardiothoracic Surgeon,\" was previously the President and Chief Medical Officer of Biostage (NASDAQ: BSTG), a micro-cap pump-and-dump engaged in quackery and which was involved with the notorious surgeon Paolo Macchiarini. BSTG was previously named Harvard Apparatus Regenerative Technology, and developed a \"bioengineered trachea implant\" – the initial surgical use of which \"was led by Professor Paolo Macchiarini\" per the BSTG S-1. A Harvard Apparatus press release noted La Francesca's promotion to EVP, after which he became President, per his LinkedIn bio.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34d8f2f0-a592-42de-83ad-7cc0ef2d044e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}